Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28781405 | 0.87 | GPR119 (0.57) | GPR119CYP2C9 | |
| SCHEMBL391312 | 0.87 | GPR119 (0.59) | GPR119CYP2C9 | |
| SCHEMBL389671 | 0.86 | GPR119 (0.60) | GPR119CYP2C9 | |
| SCHEMBL386567 | 0.82 | GPR119 (0.60) | GPR119CYP2C9 | |
| SCHEMBL390248 | 0.82 | GPR119 (0.64) | GPR119CYP2C9 | |
| SCHEMBL390044 | 0.82 | GPR119 (0.63) | GPR119CYP2C9 | |
| SCHEMBL387108 | 0.82 | GPR119 (0.55) | GPR119 | |
| SCHEMBL391164 | 0.81 | GPR119 (0.60) | GPR119CYP2C9 | |
| SCHEMBL386797 | 0.81 | GPR119 (0.77) | GPR119CYP2C9 | |
| SCHEMBL391546 | 0.80 | GPR119 (0.59) | GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101420941-A | Use of GPR119 receptor agonists for increasing bone mass and for treating osteoporosis, and related combination therapies | ARENA PHARM INC (US) | 2009-04-29 | — | — | CN | disclosed |